Gynecological Malignancies: The Critical Intersection of Advanced Imaging, Molecular Diagnostics, and Surgical Oncology

Rupa Renganathan, DMRD, DNB, FRCR, EBBI I am pleased to present this next edition of the special issue on gynecological imaging, now focusing on gynecological malignancies. The issue highlights the significant epidemiological challenges these cancers pose worldwide and emphasizes the vital role of imaging in their diagnosis and management. As the paradigms of oncologic staging and surgical intervention continue to evolve, the radiologist's ability to integrate anatomical precision with an understanding of clinical and molecular data has never been more vital. This issue provides practical, structured approaches to enhance diagnostic accuracy and multidisciplinary patient care. I thank all the authors who contributed to this edition. The revised International Federation of Gynecology and Obstetrics (FIGO) staging system for cervical cancer fundamentally shifted the paradigm from a purely clinical evaluation to a more precise, anatomically driven radiological assessment. Thakkar (Popat) et al's review examines the imaging landscape for cervical cancer staging, follow-up, and surveillance.[ 1 ] The article emphasizes magnetic resonance imaging (MRI) as the primary modality of choice for delineating tumor extent, depth of stromal invasion, and parametrial involvement. It also details the utility of multiparametric MRI in refining local staging and differentiating tumor recurrence from posttreatment changes. Gestational trophoblastic diseases (GTDs) encompass a broad spectrum, ranging from benign hydatidiform moles to highly malignant gestational trophoblastic neoplasms like choriocarcinoma. Zurale et al's review highlights the pathophysiology and the corresponding imaging hallmarks of GTD.[ 2 ] Their article expertly outlines ultrasound as the primary diagnostic tool due to its effectiveness in initial evaluation, while also clarifying the problem-solving role of pelvic MRI in complex scenarios—particularly when evaluating invasive disease or distinguishing between tumor types to guide optimal, stage-appropriate care. Uncommon uterine malignancies arising from mesenchymal, epithelial, or mixed cellular origins present distinct clinical hurdles due to their extreme rarity and high potential for aggressive recurrence. Agarwal et al provide a comprehensive overview of the classification and imaging characteristics of rare uterine malignancies, guided by the latest 2020 World Health Organization classification of female genital tumors.[ 3 ] The article highlights the critical role of advanced cross-sectional imaging, particularly MRI, in tumor detection, staging, and treatment planning. The authors detail key MRI findings, including signal intensity patterns and diffusion-weighted imaging, which help narrow differential diagnoses and inform multidisciplinary care strategies. The review article by Sud et al delves into the 2023 revision of the FIGO staging system for endometrial carcinoma.[ 4 ] The authors highlight how the incorporation of molecular subtypes—such as POLE mutations, mismatch repair deficiency, and p53 abnormalities—alongside refined anatomic definitions, significantly impacts MRI evaluation. This review emphasizes the indispensable role of MRI in preoperative staging, assessing eligibility for fertility-sparing treatments, and utilizing imaging biomarkers as potential surrogates for histological classification. Ultimately, it illustrates how integrating molecular profiling with MRI interpretation represents a critical leap toward risk-adapted therapeutic strategies. Teo and Ong offer a comprehensive and structured guide to navigating the wide-ranging diagnostic challenges of solid adnexal masses.[ 5 ] Their review outlines a methodical radiological approach that carefully categorizes these masses into ovarian and extra-ovarian origins, encompassing both gynecological and nongynecological etiologies. The authors advocate for ultrasound as the foundational first-line imaging technique, while also detailing the specific clinical scenarios where secondary evaluation with MRI or computed tomography (CT) becomes essential for accurate anatomical localization and tissue characterization. Ovarian cancer continues to be a formidable public health burden, frequently earning the moniker of a “silent killer” due to its late-stage diagnosis and aggressive peritoneal dissemination. In their review, Benjamin et al detail the complementary strengths of ultrasonography, CT, MRI, and positron emission tomography-CT (PET-CT) in the holistic management of both epithelial ovarian cancers and ovarian malignant germ cell tumors.[ 6 ] By emphasizing the critical role of precise preoperative staging for selecting optimal candidates for primary cytoreductive surgery and by highlighting emerging frontiers such as radiomics and artificial intelligence, this article provides an invaluable framework for modern clinical practice. The last review article by Shah et al provides a highly practical, compartment-based approach to complex pelvic lesions from the perspective of the onco-surgeon.[ 7 ] By systematically dividing the pelvis into anterior, middle, and posterior compartments, the authors demonstrate how a deep understanding of surgical fascial planes can optimize preoperative planning. The article underscores the utility of high-resolution MRI and hybrid modalities like PET-CT in determining precise tumor localization, guiding nerve-sparing techniques, and aiding in compartmental resections. This approach bridges the gap between radiological interpretation and surgical execution, ultimately improving both oncologic and functional patient outcomes. The included articles underscore the critical intersection of advanced radiological imaging, molecular diagnostics, and surgical oncology. We hope the insights presented in this issue will enrich your clinical practice and further elevate the standard of care provided to our patients. Publication History Article published online: 17 July 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Thieme Medical and Scientific Publishers Private Limited A-13A, Graphix Tower 1, 6th floor, Sector 62, Noida 201309, Uttar Pradesh, India